Inspirna
@inspirna.com
Inspirna is a biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need.
Inspirna's Company Logos
Inspirna's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#336699
Azure
51, 102, 153
210, 50, 40
67, 33, 0, 40
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#18181B
Woodsmoke
24, 24, 27
240, 6, 10
11, 11, 0, 89
About Inspirna
Inspirna Rgenix is a pioneering and privately-held clinical-stage biopharmaceutical brand dedicated to developing groundbreaking drugs that specifically target crucial pathways in cancer progression. Situated at 310 E 67th St, Suite 1-12, New York, NY 10065, our team of highly skilled drug developers is passionately focused on generating innovative medicines designed to treat challenging and hard-to-treat cancers. At Inspirna, we employ a unique and cutting-edge discovery platform known as RNA-DRIVEr™, exclusively licensed to us after its development by our founding scientists at Rockefeller University.
Through this platform, we are able to develop revolutionary small molecule and biologic therapeutics, pioneering first-in-class drugs that effectively target cancer drivers in oncology conditions with high unmet needs. Our relentless commitment to advancing cancer treatment means that we consistently strive to make a meaningful impact on the lives of patients. Contact us today for more information about our transformative approach to oncology drug development
Company type
Privately Held
Year founded
2010
Company size
11-50 employees
